Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified
Conditions
Interventions
Intervention1: granisetron 2mg use as antiemetic agent.: granisetron 2 mg will be given 2 minute prior to induction of anesthesia and effect will be follow up 24 hours post operatively.
Control Inter
Sponsors
SDMH
Eligibility
Inclusion criteria
Inclusion criteria: 1. Females of ASA grade I and II 2. Females of age 18-55 yrs 3. Patient who gives informed written consent 4. Females who are undergoing laproscopic hysterectomies
Exclusion criteria
Exclusion criteria: ASA ââ?°Â¥ grade III 2. Females with major systemic illness 3. Patient with history of PONV in previous surgery 4. Patient with history of vomiting and ryleââ?¬•s tube in situ in last 24 hours 5. Patient with history of allergy to the drug 6. Patient who refuse to give consent 7. Patient having neurological and renal diseases. 8. Pregnant females
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| incidence of post operative nausea and vomitingTimepoint: for 24 hours postoperatively | — |
Secondary
| Measure | Time frame |
|---|---|
| assess demand of rescue antiemetic. compare side effects of ondansetron and granisetronTimepoint: intraoperatively and for 24 hours post operatively | — |
Countries
India
Contacts
Public ContactToshi gupta
Santokba durlabhji memorial hospital
Outcome results
None listed